Background Data on long-term cardiovascular outcomes in systemic lupus erythematosus
(SLE) are sparse. Objectives This study sought to examine the long-term risk and prognosis …

Objective. To examine the mortality and cardiovascular disease (CVD) burden among a
population-based cohort of patients with systemic lupus erythematosus (SLE) with …

Awareness of the impact of cardiovascular disease on the late morbidity and mortality in
patients with Systemic Lupus Erythematosus (SLE) is increasing. Clinical events secondary …

Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by a
constellation of cardiovascular (CV) and non-CV manifestations. Even though CV …

Background This study evaluated the risk of acute myocardial infarction (AMI) and mortality
among patients with systemic lupus erythematosus (SLE) in two nationwide retrospective …

Background Although case series suggest a higher burden of cardiovascular risk factors in
patients with systemic lupus erythematosus (SLE) compared with the general population, the …

Background Cardiovascular disease represents an important cause of morbidity and
mortality in patients with a diagnosis of systemic lupus erythematosus (SLE), due to a …

Objective To estimate the future risk and time trends of newly diagnosed myocardial
infarction (MI), ischemic stroke, or both (cardiovascular disease [CVD]) in individuals with …

Objective. To determine the features predictive of atherosclerotic cardiovascular damage in
patients with SLE. Methods. SLE LUMINA (LUpus in MInorities: NAture vs nurture) patients …

Objective. We previously reported the effect of certain factors on cardiovascular disease
(CVD) in 250 women with systemic lupus erythematosus (SLE) followed for 8 years. The aim …